Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
CN Stock MarketDetailed Quotes
300267 Hunan Er-kang Pharmaceutical
- 3.02
- +0.16+5.59%
Market Closed May 6 15:00 CST
6.23BMarket Cap-17.87P/E (TTM)
3.13High2.93Low1.02MlotVolume2.96Open2.86Pre Close307.39MTurnover7.18%Turnover RatioLossP/E (Static)2.06BShares3.8852wk High1.40P/B4.30BFloat Cap2.0352wk Low3.43Limit Up1.42BShs Float23.06Historical High2.29Limit Down6.99%Amplitude1.20Historical Low--Dividend TTM3.01Avg Price407.01KlotAsk--Div YieldTTM100Lot Size604.83KlotBid
Hunan Er-kang Pharmaceutical Key Stats
Hunan Er-kang Pharmaceutical Q1 2025 Earnings Date
Currency：CNYApr 23, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 353.55M | -- |
+28.19% | |||
| EPS | -- | 0.01 | -- |
+871.43% |
Analyst Rating
No Data
Hunan Er-kang Pharmaceutical Earnings Estimates
Revenue
EPS
EBIT
No Data
Hunan Er-kang Pharmaceutical Earnings Reports
Read more
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting